The VP, Legal of Exactech (NASDAQ: EXAC) is Selling SharesBy Carrie Williams
In addition to Donna Edwards, 12 other EXAC executives reported Sell trades in the last month.
Based on Exactech’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $66.23 million and GAAP net loss of $11.79 million. In comparison, last year the company earned revenue of $62.73 million and had a net profit of $4.15 million. The company has a one year high of $29 and a one year low of $18.14. EXAC’s market cap is $347.9M and the company has a P/E ratio of 2425.
In the last 30 days, insiders have sold $1.31M worth of EXAC shares and purchased $104.2K worth of EXAC shares. The insider sentiment on Exactech has been negative according to 73 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Donna Edwards’ trades have generated a -7.8% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Exactech, Inc. develops, manufactures, markets, distributes, and sells orthopedic implant devices; related surgical instrumentation; and biologic services to hospitals and physicians. It also engages in the sale and distribution of joint replacement systems. The company operates its business through following segments: Knee; Hip; Biologics and Spine; Extremity; and Other. The Knee segment provides comprehensive solutions for partial, primary and revision total knee arthroplasty. The Hip segment offers hip solutions, which address the continuum of hip arthroplasty. The Biologics and Spine segment manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products which contain human allograft. The Extremity segment includes treatment options for both degenerative disease as well as trauma. The Others segment comprises of Cemex bone cement system and AcuDriver automated osteotome system. The company was founded by R. William Petty, Betty B. Petty, and Gary J. Miller on November 8, 1985 and is headquartered in Gainesville, FL.